Milestone Pharmaceuticals (MIST) Net Shares Issued and Repurchased (2018 - 2026)

Milestone Pharmaceuticals (MIST) has reported Net Shares Issued and Repurchased for 8 consecutive years, with $2.1 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Net Shares Issued and Repurchased rose 85.12% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 85.12% YoY), and the FY2025 full-year result was $1.5 million, down 7.57% from the prior year.
• Net Shares Issued and Repurchased advanced to $2.1 million in Q1 2026 per MIST's latest filing, from $1.5 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $2.1 million in Q1 2026 and bottomed at $386053.0 in Q1 2024.
• Historically, Net Shares Issued and Repurchased has averaged $1.5 million across 5 years, with a median of $1.5 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased sank 74.05% in 2024, then surged 198.25% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $1.8 million in 2022, then grew by 4.73% to $1.9 million in 2023, then slipped by 11.91% to $1.7 million in 2024, then declined by 7.57% to $1.5 million in 2025, then soared by 39.6% to $2.1 million in 2026.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $2.1 million, $1.5 million, and $1.2 million for Q1 2026, Q4 2025, and Q1 2025 respectively.